| Literature DB >> 27574683 |
Christopher Tam Song1, Jolie Hwee2, Colin Song3, Bien Keem Tan2, Si Jack Chong2.
Abstract
BACKGROUND: With various changes implemented such as perioperative antibiotics for tangential excision, this retrospective study reviews the infection profile of burn patients at Singapore's only centralized burns unit. Worldwide, the appearance of multidrug-resistant (MDR) strains of Acinetobacter baumannii (A. baumannii) continues to worsen patient outcomes. This study also surveys the role of blood cultures in burns at our unit.Entities:
Keywords: Acinetobacter baumannii; Blood cultures; Burns; Drug resistant; Epidemiology; Infection; Singapore
Year: 2016 PMID: 27574683 PMCID: PMC4964067 DOI: 10.1186/s41038-016-0038-8
Source DB: PubMed Journal: Burns Trauma ISSN: 2321-3868
Fig. 1Patient selection process according to inclusion criteria for the study
Demographics of patients included in the study
| TBSA group | ||||||
|---|---|---|---|---|---|---|
| Variables | Total | I | II | III | IV | V |
| Patients, | 452 (100) | 277 (61.3) | 85 (18.8) | 50 (11.1) | 29 (6.4) | 11(2.4) |
| Age, year | ||||||
| Median | 40 | 40 | 42 | 35.5 | 37 | 48 |
| Range | 5–94 | 14–94 | 18–83 | 54–82 | 5–70 | 5–70 |
|
| – | – | 0.832 | 0.367 | 0.185 | 0.161 |
| Sex | ||||||
| Male, | 255 (56.4) | 151 (54.5) | 43 (50.6) | 35 (70.0) | 23 (79.30) | 3 (27.3) |
|
| – | – | 0.707 | 0.123 | 0.013 | 0.538 |
| Nationality | ||||||
| Foreign | 176 (38.9) | 84 (30.3) | 41 (48.2) | 31 (62.0) | 18 (62.1) | 2 (18.2) |
|
| – | – | 0.03 | <0.001 | <0.001 | 0.384 |
| TBSA % | ||||||
| Median | 6.0 | 3.0 | 13.0 | 26.0 | 50.5 | – |
| Range | 0.1–90.0 | 0.1–9.5 | 10.0–19.5 | 20.0–38.0 | 40.0–90.0 | – |
| Length of stay, day | ||||||
| Median | 11 | 10 | 13 | 23.5 | 27 | 6 |
| Range | 1–221 | 1–151 | 1–56 | 5–149 | 1–221 | 2–13 |
|
| – | – | <0.001 | <0.001 | 0.013 | 0.582 |
| Surgery, | 365 (80.8) | 222 (80.1) | 73 (85.9) | 45 (90.0) | 25 (86.2) | 0 (0) |
|
| – | – | 0.236 | 0.105 | 0.434 | – |
| Patients with positive cultures, | 272 (60.2) | 172 (62.1) | 35 (41.2) | 36 (72.0) | 25 (86.2) | 4 (36.4) |
|
| – | – | 0.629 | 0.236 | 0.030 | 0.707 |
TBSA total body surface area, I TBSA burn < 10 %, II 10 % ≤ TBSA burn < 20 %, III 20 % ≤ TBSA burn < 40 %, IV TBSA burn ≥ 40 %, V Inhalational injury
Incidence of each organism cultured in total population sample and according to TBSA group
| Organism | Total infected, | I, | II, | III, | IV, | V, |
|---|---|---|---|---|---|---|
| Total no. of patients | 452 | 277 | 85 | 50 | 29 | 11 |
|
| 80 (17.7) | 51 (18.4) | 8 (9.4) | 11 (22.0) | 10 (34.5) | 0 |
|
| 80 (17.7) | 59 (21.3) | 8 (9.4) | 10 (20.0) | 2 (6.9) | 1 (9.1) |
| MDR | 54 (11.9) | 8 (2.9) | 6 (7.1) | 17 (34) | 22 (75.9) | 1 (9.1) |
| MRSA | 45 (10.0) | 22 (7.9) | 7 (8.2) | 8 (16) | 8 (27.6) | 0 |
|
| 42 (9.3) | 27 (9.7) | 7 (8.2) | 5 (10) | 3 (10.3) | 0 |
|
| 37 (8.2) | 25 (9.0) | 6 (7.1) | 5 (10) | 1 (3.4) | 0 |
|
| 34 (7.5) | 14 (5.1) | 5 (5.9) | 6 (12) | 8 (27.6) | 1 (9.1) |
|
| 33 (7.3) | 17 (6.1) | 1 (1.2) | 9 (18) | 1 (3.4) | 0 |
|
| 30 (6.6) | 10 (3.6) | 1 (1.2) | 8 (16) | 10 (34.5) | 1 (9.1) |
| MDR | 18 (4.0) | 2 (0.7) | 4 (4.7) | 8 (16) | 4 (13.8) | 0 |
|
| 13 (2.9) | 8 (2.9) | 0 (0) | 1 (2) | 3 (10.3) | 1 (9.1) |
| MDR | 13 (2.9) | 9 (3.2) | 3 (3.5) | 0 (0) | 1 (3.4) | 0 |
|
| 12 (2.7) | 8 (2.9) | 0 (0) | 3 (6) | 1 (3.4) | 0 |
|
| 11 (2.4) | 5 (1.8) | 1 (1.2) | 1 (2) | 4 (13.8) | 0 |
| MDR | 11 (2.4) | 3 (1.1) | 0 (0) | 5 (10) | 3 (10.3) | 0 |
| Group G | 8 (1.8) | 6 (2.2) | 0 (0) | 2 (4) | 0 (0) | 0 |
|
| 8 (1.8) | 6 (2.2) | 0 (0) | 1 (2) | 1 (3.4) | 0 |
|
| 7 (1.5) | 3 (1.1) | 3 (3.5) | 0 (0) | 1 (3.4) | 0 |
| MDR coagulase-negative | 6 (1.3) | 3 (1.1) | 0 (0) | 3 (6) | 0 (0) | 0 |
| MDR | 6 (1.3) | 4 (1.4) | 0 (0) | 1 (2) | 1 (3.4) | 0 |
| Group A | 5 (1.1) | 4 (1.4) | 0 (0) | 1 (2) | 0 (0) | 0 |
| Group B | 5 (1.1) | 5 (1.8) | 0 (0) | 0 (0) | 0 (0) | 0 |
| MDR | 4 (0.9) | 0 (0) | 1 (1.2) | 0 (0) | 3 (10.3) | 0 |
| MDR | 4 (0.9) | 1 (0.4) | 0 (0) | 2 (4) | 1 (3.4) | 0 |
|
| 2 (0.4) | 0 (0) | 0 (0) | 0 (0) | 2 (6.9) | 0 |
|
| 2 (0.4) | 0 (0) | 0 (0) | 2 (4) | 0 (0) | 0 |
|
| 2 (0.4) | 1 (0.4) | 1 (1.2) | 0 (0) | 0 (0) | 0 |
|
| 2 (0.4) | 1 (0.4) | 0 (0) | 1 (2) | 0 (0) | 0 |
|
| 1 (0.2) | 1 (0.4) | 0 (0) | 0 (0) | 0 (0) | 0 |
|
| 1 (0.2) | 1 (0.4) | 0 (0) | 0 (0) | 0 (0) | 0 |
|
| 1 (0.2) | 1 (0.4) | 0 (0) | 0 (0) | 0 (0) | 0 |
|
| 1 (0.2) | 0 (0) | 0 (0) | 0 (0) | 1 (3.4) | 0 |
|
| 1 (0.2) | 0 (0) | 0 (0) | 0 (0) | 1 (3.4) | 0 |
|
| 1(0.2) | 0 (0) | 1 (1.2) | 0 (0) | 0 (0) | 0 |
| MDR | 1(0.2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (9.1) |
| MDR | 1 (0.2) | 1 (0.4) | 0 (0) | 0 (0) | 0 (0) | 0 |
TBSA total burn serface area, MDR multidrug-resistant, MRSA Methicillin-resistant Staphylococcus aureus
Yield of the various types of culture in total and according to TBSA group
| TBSA group | ||||||
|---|---|---|---|---|---|---|
| Culture | Total, n (%) | I, n (%) | II, n (%) | III, n (%) | IV, n (%) | V, n (%) |
| Wound | 323 | 196 | 64 | 46 | 17 | 0 |
| Yield | 170 (52.6) | 104 (53.1) | 25 (39.1) | 32 (69.6) | 9 (52.9) | 0 |
| Tissue | 1070 | 381 | 174 | 231 | 284 | 0 |
| Yield | 556 (52.0) | 207 (54.3) | 52 (29.9) | 116 (50.2) | 181 (63.7) | 0 |
| Endotracheal | 163 | 29 | 6 | 33 | 86 | 9 |
| Yield | 64 (39.3) | 8 (27.6) | 2 (33.3) | 15 (45.5) | 36 (41.9) | 3 (33.3) |
| Line | 149 | 20 | 2 | 44 | 82 | 1 |
| Yield | 41 (27.5) | 5 (25.0) | 1 (50.0) | 13 (29.5) | 22 (26.8) | 0 |
| Urine | 267 | 83 | 17 | 75 | 83 | 9 |
| Yield | 52 (19.5) | 20 (24.1) | 0 (0) | 18 (24) | 12 (14.5) | 2 (22.2) |
| Blood | 711 | 123 | 57 | 205 | 315 | 11 |
| Yield | 101 (14.2) | 2 (1.6) | 0 (0) | 23 (11.2) | 74 (23.5) | 2 (18.2) |
TBSA total body surface area, I TBSA burn < 10 %, II 10 % ≤ TBSA burn < 20 %, III 20 % ≤ TBSA burn < 40 %, IV TBSA burn ≥ 40 %, V inhalational injury
Antibiotic resistance profile of multidrug-ressitant (MDR) Acinetobacter baumannii (A. baumannii) isolates
| No. | Isolate | No. of cultures in each profile |
|---|---|---|
| 1 | Ceft + Pip/Taz + Amp | 14 |
| 2 | Ceft + Cep + Cefe + Ami | 10 |
| 3 | Amp + Cefe + Gen | 6 |
| 4 | Cep + Cip + Cot | 5 |
| 5 | Ceft + Mero + Erta | 4 |
| 6 | Cip + Imi + Min | 3 |
| 7 | Pip/Taz + Cep + Cefe | 2 |
| 8 | Amp + Cep + Cip + Min | 2 |
| 9 | Pip/Taz + Cep + Cot + Min | 2 |
| 10 | Ceft + Pip/Taz + Ami + Mer + Pol | 2 |
| 11 | Ceft + Cip + Cot + Gen + Ert | 1 |
| 12 | Ceft + Pip/Taz + Amp + Cepha + Cefe + Cip + Ami + Cot + Gen + Mero + Imi + Ert | 1 |
| Total | 54 |
Ceft ceftriaxone, Pip/Taz piperacillin/tazobactam, Amp ampicillin, Cep cephalothin, Cefe cefepime, Cip ciprofloxacin, Ami amikacin, Cot cotrimoxazole, Gen gentamicin, Mer meropenem, Imi imipenem, Ert ertapenem, Min minocycline, and Pol polymyxin B
Univariate analysis of patient variables for acquisition of multidrug-ressitant (MDR) Acinetobacter baumannii (A. baumannii) infection
| Acquired MDR | Univariate analysis | |||||
|---|---|---|---|---|---|---|
| Variable | Yes ( | No ( |
| OR | 95 % CI |
|
| Sex | ||||||
| Male | 36 | 219 | 0.11 | – | – | – |
| Nationality | ||||||
| Local | 27 | 249 | 0.076 | 1.67 | 0.94–2.96 | 0.078 |
| Age (years), mean±SD | 44.3 ± 16.4 | 43.1 ± 17.4 | 0.629 | – | – | – |
| Length of stay (days), mean±SD | 45.8 ± 43.8 | 12.3 ± 8.7 | <0.001 | 1.10 | 1.07–1.13 | <0.001 |
| TBSA group | ||||||
| I | 8 | 269 | – | – | – | – |
| II | 6 | 79 | 0.14 | 2.55 | 0.86–7.58 | 0.091 |
| III | 17 | 33 | <0.001 | 17.32 | 6.94–43.24 | <0.001 |
| IV | 22 | 7 | <0.001 | 105.68 | 35.05–318.60 | <0.001 |
| V | 1 | 10 | <0.001 | 3.36 | 0.38–29.53 | 0.274 |
| Intubation | 26 | 42 | <0.001 | 7.87 | 4.23–14.66 | <0.001 |
| Number of surgeries, mean±SD | 3.4 ± 4.8 | 1.4 ± 1.9 | 0.03 | 1.23 | 1.11–1.35 | <0.001 |
| Prior infection | ||||||
|
| 5 | 32 | 0.79 | – | – | – |
| MRSA | 9 | 36 | 0.79 | – | – | – |
|
| 12 | 68 | 0.353 | – | – | – |
| Cause of burn | ||||||
| Scalding | 8 | 132 | 0.001 | 0.35 | 0.16–0.76 | 0.008 |
| Flame | 8 | 81 | – | 0.68 | 0.31–1.50 | 0.339 |
| Blast | 14 | 40 | – | 3.13 | 1.57–6.25 | 0.001 |
| Others | 24 | 145 | – | 1.40 | 0.79–2.48 | 0.255 |
| Days to admission (days), mean±SD | 2.6 ± 5.7 | 4.9 ± 15.8 | 0.032 | 0.963 | 0.91–1.02 | 0.196 |
MDR A. baumannii multidrug-ressitant Acinetobacter baumannii, OR odds ratio, CI confidence interval, TBSA total body surface area, I TBSA burn < 10 %, II 10 % ≤ TBSA burn < 20 %, III 20 % ≤ TBSA burn < 40 %, IV TBSA burn ≥ 40 %, V inhalational injury, MRSA Methicillin-resistant Staphylococcus aureus
Multivariate analysis of patient variables for acquisition of MDR A. baumannii infection
| Multivariate analysis | |||
|---|---|---|---|
| Variable | OR | 95 % CI |
|
| Length of stay | 1.09 | 1.0–1.13 | <0.001 |
| TBSA group | |||
| III | 5.16 | 1.77–15.03 | 0.003 |
| IV | 69.28 | 15.21–315.63 | <0.001 |
| Intubation | 1.73 | 0.45–3.73 | 0.309 |
| Number of surgeries | 0.90 | 0.76–1.03 | 0.140 |
| Cause of burn | |||
| Blast | 0.49 | 0.09–1.12 | 0.254 |
MDR A. baumannii multidrug-ressitant Acinetobacter baumannii, OR odds ratio, CI confidence interval, TBSA total body surface area, III 20 % ≤ TBSA burn < 40 %, IV TBSA burn ≥ 40 %
Univariate analysis of patient variables for positive blood culture
| Blood culture | Univariate analysis | |||||
|---|---|---|---|---|---|---|
| Variables | Positive ( | Negative ( |
| OR | 95 % CI |
|
| Age (years), mean±SD | 38.1 ± 15.8 | 46.1 ± 16.0 | 0.010 | 0.97 | 0.94–0.99 | 0.011 |
| Sex, n | ||||||
| Male | 26 | 88 | 0.147 | 1.89 | 0.79–4.47 | 0.151 |
| Nationality, n | ||||||
| Local | 13 | 82 | 0.029 | 0.43 | 0.20–0.93 | 0.032 |
| Foreigner | 21 | 57 | – | 2.32 | 1.08–5.02 | |
| TBSA, n | ||||||
| I | 2 | 61 | <0.001 | – | – | – |
| II | 0 | 33 | <0.001 | 0 | 0 | 0.998 |
| III | 11 | 31 | 0.220 | 10.82 | 2.26–51.89 | 0.003 |
| IV | 20 | 8 | <0.001 | 76.25 | 14.94–389.10 | <0.001 |
| V | 1 | 6 | 0.720 | 5.08 | 0.40–64.63 | 0.210 |
| Cause, n | ||||||
| Flame | 15 | 29 | 0.029 | 3.00 | 1.36–6.61 | 0.007 |
| Scalding | 4 | 39 | – | 0.34 | 0.14–1.72 | 0.057 |
| Blast | 6 | 28 | – | 0.85 | 0.32–2.25 | 0.743 |
| Others | 9 | 43 | – | 0.80 | 0.35–1.87 | 0.611 |
| MDR | 18 | 30 | 0.001 | 4.09 | 1.86–8.97 | <0.001 |
| Length of stay, day | 18.3 ± 16.3 | 53.9 ± 48.2 | <0.001 | 1.05 | 1.03–1.07 | <0.001 |
| Days to admission, day | 2.1 ± 4.3 | 2.5 ± 5.4 | 0.619 | 0.98 | 0.90–1.07 | 0.664 |
| Days to first surgery, day | 4.6 ± 6.9 | 5.5 ± 7.6 | 0.658 | 0.98 | 0.92–1.05 | 0.535 |
| Number of surgeries | 1.8 ± 1.8 | 6.2 ± 1.1 | <0.001 | 1.44 | 1.22–1.70 | <0.001 |
OR odds ratio, CI confidence interval, TBSA total body surface area, I TBSA burn < 10 %, II 10 % ≤ TBSA burn < 20 %, III 20 % ≤ TBSA burn < 40 %, IV TBSA burn ≥ 40 %, V inhalational injury, MDR A. baumannii multidrug-ressitant Acinetobacter baumannii
Multivariate analysis of patient variables for positive blood culture
| Multivariate analysis | |||
|---|---|---|---|
| Variables | OR | 95 % CI |
|
| Nationality | |||
| Foreigner | 1.82 | 0.47–7.15 | 0.388 |
| TBSA group | |||
| III | 7.14 | 1.55–32.94 | 0.012 |
| IV | 51.58 | 7.52–353.78 | <0.001 |
| Cause | |||
| Flame | 1.66 | 0.41–6.76 | 0.482 |
| Length of stay | 1.03 | 1.00–1.06 | 0.022 |
| Number of surgeries | 1.11 | 0.86–1.44 | 0.421 |
| MDR | 0.79 | 0.15–4.29 | 0.786 |
OR odds ratio, CI confidence interval, TBSA total body surface area, III 20 % ≤ TBSA burn < 40 %, IV TBSA burn ≥ 40 % MDR A. baumannii multidrug-ressitant Acinetobacter baumannii